Lyotek research peptides now reach more than 170 countries
Through its exclusive distributor, Lyotek research peptides now reach laboratories in more than 170 countries from the laboratory in Switzerland.
All press releases
Five facility certificates published
Certification Assurance International issued Lyotek Labs five facility certificates on 27 October 2026, and all of them are now published on this site as the issuer's PDFs.
The quality management system is registered to ISO 9001:2026. The laboratory also holds certificates of compliance for cGMP manufacturing, for its testing laboratory to ISO/IEC 17025:2017, for its cleanrooms to EN/ISO 14644-1:2015 and for storage and distribution to Good Distribution Practices.
Each certificate runs until 26 October 2027. The certifications page shows its number, its dates and its scope as printed, and anyone can confirm a certificate with the issuer at cert-assure.com or by the QR code on the document.
These certificates cover how the laboratory works. The result for a particular lot is on the certificate of analysis for that lot.
Lyotek products are supplied for research use only.
More from the laboratory
Our exclusive distributor expands to the Middle East, Southeast Asia and Latin America
Lyotek's exclusive distributor has extended its coverage to three new regions, which brings local support to laboratories there.
Growth hormone axis range opens with Tesamorelin, CJC-1295 and Ipamorelin
Three research peptides open a new section of the Lyotek catalogue: Tesamorelin at 20 mg, and CJC-1295 and Ipamorelin at 10 mg each.